Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,337,747
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
66,455,672
-
Shares change
-
+2,196
-
Total reported value, excl. options
-
$443,090,314
-
Value change
-
-$748,812
-
Put/Call ratio
-
356%
-
Number of buys
-
38
-
Number of sells
-
-39
-
Price
-
$6.67
Significant Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) as of Q1 2023
101 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,455,672 shares
of 105,337,747 outstanding shares and own 63% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (14,567,176 shares), FMR LLC (7,940,542 shares), Novo Holdings A/S (6,071,703 shares), VIKING GLOBAL INVESTORS LP (4,909,146 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3,933,137 shares), EcoR1 Capital, LLC (3,493,194 shares), Deep Track Capital, LP (3,068,259 shares), Cormorant Asset Management, LP (2,946,887 shares), BlackRock Inc. (2,871,007 shares), and CITADEL ADVISORS LLC (2,768,438 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.